Comparison of CGS15943, ZM241385 and SCH58261 as antagonists at human adenosine receptors

被引:166
作者
Ongini, E
Dionisotti, S
Gessi, S
Irenius, E
Fredholm, BB
机构
[1] Schering Plough Res Inst, I-20132 Milan, Italy
[2] Karolinska Inst, Dept Physiol & Pharmacol, Sect Mol Neuropharmacol, S-17177 Stockholm, Sweden
关键词
human adenosine receptors; A(2A) adenosine antagonists; CGS; 15943; ZM; 241385; SCH; 58261;
D O I
10.1007/PL00005326
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three structurally related non-xanthine compounds, CGS 15943, ZM 241385 and SCH 58261, are potent A(2A) adenosine receptor antagonists and have been used as tools in many pharmacological studies. We have now characterized their affinity and selectivity profile on human adenosine receptors stably transfected into either CHO cells (A(1) and A(2B) receptors) or HEK-293 cells (A(2A) and A(3) receptors). In binding studies using [H-3]SCH 58261 as a radioligand, the three compounds were equally potent at A(2A) receptors, their K-i value being less than 1 nM. Affinity for A(1) and A(3) receptors was measured using [H-3]DPCPX and [I-125]AB-MECA as radioligands. Given the lack of selective ligands, interaction with A(2B) receptors was assessed using the cAMP accumulation assay following stimulation by the adenosine receptor agonist N-ethylcarboxamidoadenosine (NECA). CGS 15943 was almost as potent at A(1) receptors (K-i 3.5 nM) as at A(2A) receptors, showed moderate affinity for A(3) receptors (K-i 95 nM) and also interacted with A(2B) Peceptors (K-i 44 nM; pA(2) 7.5). ZM 241385 showed little affinity for A(1) receptors (K-i 255 nM), and did not interact with A(3) receptors (K-i >10 mu M); however, it displayed moderate affinity for A(2B) receptors (K-i 50 nM; pA(2) 7.3). SCH 58261 had weak affinity for A(1) receptors (K-i 287 nM), no interaction with A(3) receptors (K-i > 10 mu M), and showed negligible interaction with A(2B) receptors (K-i 5 mu M; pA(2) 6.0). These data indicate that SCH 58261 is the most selective A2A antagonist currently available. Moreover, the different receptor selectivity of these three chemically related compounds provides useful information to progress with structure-activity relationship studies.
引用
收藏
页码:7 / 10
页数:4
相关论文
共 24 条
  • [1] Characterization of the human brain putative A(2B) adenosine receptor expressed in Chinese hamster ovary (CHO.A(2B4)) cells
    Alexander, SPH
    Cooper, J
    Shine, J
    Hill, SJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (06) : 1286 - 1290
  • [2] SYNTHESIS OF NEW PYRAZOLO[4,3-E]1,2,4-TRIAZOLO[1,5-C] PYRIMIDINE AND 1,2,3-TRIAZOLO[4,5-E]1,2,4-TRIAZOLO[1,5-C] PYRIMIDINE DISPLAYING POTENT AND SELECTIVE ACTIVITY AS A(2A) ADENOSINE RECEPTOR ANTAGONISTS
    BARALDI, PG
    MANFREDINI, S
    SIMONI, D
    ZAPPATERRA, L
    ZOCCHI, C
    DIONISOTTI, S
    ONGINI, E
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (21) : 2539 - 2544
  • [3] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [4] Characterization of human A(2A) adenosine receptors with the antagonist radioligand [H-3]-SCH 58261
    Dionisotti, S
    Ongini, E
    Zocchi, C
    Kull, B
    Arslan, G
    Fredholm, BB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (03) : 353 - 360
  • [5] Dionisotti S, 1996, J PHARMACOL EXP THER, V278, P1209
  • [6] Pharmacological characterization of adenosine A2B receptors -: Studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes
    Feoktistov, I
    Biaggioni, I
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 55 (05) : 627 - 633
  • [7] Fredholm B.B, 1998, IUPHAR COMPENDIUM RE, P48
  • [8] Adenosine A3 receptors:: novel ligands and paradoxical effects
    Jacobson, KA
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (05) : 184 - 191
  • [9] JARVIS MF, 1991, MOL PHARMACOL, V39, P49
  • [10] Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A(3) receptor subtype
    Kim, YC
    Ji, XD
    Jacobson, KA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (21) : 4142 - 4148